Pfizer Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-248.0M | $2.69B | $3.54B | $2.91B | $2.97B | $4.47B | $41.0M | $3.12B |
| Depreciation & Amortization | $1.62B | $1.61B | $1.66B | $1.63B | $1.62B | $1.76B | $1.73B | $1.74B |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | $1.20B | — | — | $1.30B |
| Stock-Based Compensation | — | $272.0M | — | — | $170.0M | — | — | $220.0M |
| Net Cash from Operating Activities | $835.0M | $2.62B | $4.60B | $-582.0M | $2.34B | $6.71B | $-1.78B | $1.09B |
| Investing Activities | ||||||||
| Capital Expenditures | $533.0M | $436.0M | $602.0M | $618.0M | $564.0M | $651.0M | $637.0M | $704.0M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $785.0M | — | — | $3.27B | — | — | $1.73B |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $-2.86B | — | — | $-5.23B | — | — | $-4.93B |
| Net Change in Cash | — | $563.0M | — | — | $375.0M | — | — | $-2.14B |
| Free Cash Flow | $302.0M | $2.18B | $4.00B | $-1.20B | $1.77B | $6.06B | $-2.42B | $386.0M |